₹93.49
+0.10 (+0.11%)
As of 22 Sept 2026, Anuh Pharma Ltd share price is ₹93.49. The stock opened at ₹93.49 and had closed at ₹93.39 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹66.72 and a high of ₹99.50. In terms of performance, Anuh Pharma Ltd share price has increased by 31.03% over the past six months and has increased by 8.34% over the last year.
ANUHPHR Stock Price Chart
Anuh Pharma Ltd Overview
Market cap₹937 Crs
Volume13,297
Prev. Close₹93.39
Year range₹66.72 - ₹99.50
ISININE489G01022
About ANUHPHR
Anuh Pharma is engaged in the business of manufacturing and selling of Bulk drugs and chemicals.
Anuh Pharma Ltd Historical Performance
1 Month Return23.32%
6 Month Return25.19%
3 Year Return45.62%
3 Month Return19.11%
1 Year Return8.85%
5 Year Return58.38%
Anuh Pharma Ltd Fundamentals
ROCE(TTM)15.53%
P/E Ratio (TTM)21.20
P/B Ratio2.66
Debt to Equity0.00
ROE11.65%
EPS (TTM)4.41
Dividend Yield1.60%
Book Value35.14
Profit Margin5.67%
Operating Margin7.17%
Anuh Pharma Ltd Financials
| Indicator | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Revenue | 776.02 | 670.97 | 659.10 | 533.60 | 491.85 |
| EBITDA | 66.07 | 70.37 | 87.24 | 57.39 | 52.04 |
| Net Profit | 41.05 | 47.35 | 60.06 | 36.18 | 30.56 |
| EPS | 4.10 | 9.45 | 11.98 | 7.22 | 6.10 |
Anuh Pharma Ltd Technical Analysis
| Indicator | Value |
|---|---|
| Support 1 (S1) | 91.84 |
| Resistance 1 (R1) | 94.97 |
| Pivot Point | 93.42 |
Anuh Pharma Ltd Dividend History
| Ex Date | Dividends Date | Record Date | Dividend Type | Dividend Details |
|---|---|---|---|---|
| 05-Aug-2026 | 20-May-2026 | 05-Aug-2026 | Final | ₹1.50 |
| 14-Aug-2025 | 23-May-2025 | 15-Aug-2025 | Final | ₹1.50 |
| 16-Aug-2024 | 17-May-2024 | 16-Aug-2024 | Final | ₹2.50 |
| 11-Aug-2023 | 19-May-2023 | 11-Aug-2023 | Final | ₹2.00 |
| 03-Aug-2022 | 14-May-2022 | 05-Aug-2022 | Final | ₹1.75 |
ANUHPHR Key Leadership Details
Last Updated: Mar 2026
| Name | Position |
|---|---|
| Arun Todarwal | Chairman |
| Bipin N Shah | Non Executive Director |
| Ritesh B Shah | Managing Director |
Anuh Pharma Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Sun Pharmaceutical Industries LtdSUNPHARMA | ₹1,868.90+1.72% | ₹4,19,727.66 | 38.32 | 13.74% |
| Divis Laboratories LtdDIVISLAB | ₹9,410.50+0.38% | ₹1,67,235.91 | 67.46 | 15.32% |
| Torrent Pharmaceuticals LtdTORNTPHARM | ₹4,970.00+2.69% | ₹1,46,951.32 | 64.68 | 25.49% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Anuh Pharma Ltd today is ₹93.49 on NSE and ₹93.49 on BSE.
- The 52-week high of Anuh Pharma Ltd is ₹99.50, while the 52-week low is ₹66.72.
- The current market capitalisation of Anuh Pharma Ltd is approximately ₹937 crore.
- The P/E (Price-to-Earnings) ratio of Anuh Pharma Ltd is 21.20. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Anuh Pharma Ltd is 2.66. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To buy Anuh Pharma Ltd shares, you first need to open a demat account before you can place an order. Here's the process:
• Open a demat account online using your PAN, Aadhaar and bank details.
• Add funds to your trading account via UPI or net banking.
• Search for ANUHPHR on TradeMobi or the Anand Rathi web platform.
• Place your order
• Track your holdings in the portfolio section. - Over the past 3 years, Anuh Pharma Ltd has delivered a return of approximately 45.62%. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Anuh Pharma Ltd comprises different categories of shareholders. As of Jun 2026, the shareholding is approximately 71.80% promoters, 0.01% FIIs, 0.00% DIIs, and 23.49% public shareholders.
Download TradeMobi App
- Real-Time Market Data
- Advanced Trading Tools
- Expert-Backed Research
